Loading clinical trials...

COMPLETEDNANCT00804596

Evaluation of Labeling Comprehension and Performance of a New Blood Glucose Meter System

The purpose of the study was to evaluate the acceptability of product user guides for untrained subjects and to evaluate the performance of the system with lay users and healthcare providers (HCPs).

Lead sponsor: Ascensia Diabetes Care•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

A Natural History Study of Metabolic Sizing in Health and Disease

NCT05398783 · Metabolic Disorders, Cancer, and more

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

RECRUITINGNA

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT01399385 · Healthy, Obesity, and more

RECRUITINGEARLY Phase 1

Autologous CD6-CAR Treg Cells for Patients With Stage 3 Type 1 Diabetes

NCT07395050 · Stage 3 Type 1 Diabetes

RECRUITINGPhase 3

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

NCT07222137 · Diabetes Mellitus, Type 1

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 29, 2016Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment74

Start dateDec 2008

Last updatedFeb 29, 2016

Condition

Diabetes

Locations shown

International Diabetes Center

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 29, 2016Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions